INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $81,000 | +28.6% | 69,548 | 0.0% | 0.01% | +18.2% |
| Q2 2020 | $63,000 | +8.6% | 69,548 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $58,000 | -13.4% | 69,548 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $67,000 | -6.9% | 69,548 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $72,000 | -42.4% | 69,548 | 0.0% | 0.01% | -43.5% |
| Q2 2019 | $125,000 | -4.6% | 69,548 | 0.0% | 0.02% | -8.0% |
| Q1 2019 | $131,000 | +219.5% | 69,548 | +98.7% | 0.02% | +177.8% |
| Q4 2018 | $41,000 | -56.8% | 35,000 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $95,000 | – | 35,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |